1. Resources and Training
  2. Oncology
  3. Product resources and training
  4. Video: Dr Paul Nathan discusses the COMBI-AD trial

Prescribing information

 

Video: Dr Paul Nathan discusses the COMBI-AD trial

_

Dr Paul Nathan presents the data on the use of Tafinlar (dabrafenib) + Mekinist (trametinib) in the adjuvant setting for management of adult patients with BRAF V600 stage III melanoma, following complete resection. Filmed August 2018.

 
Rate this content: 
No votes yet
TMC20-C016 March 2020
Oncology
Video
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]